COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN COSTA RICA

J. Ordonez,F. Hernandez,G. Rodriguez, J. Estrada,A. Ordonez,J. Hidalgo Godinez, K. Villalobos

VALUE IN HEALTH（2022）

引用 0|浏览0

暂无评分

摘要

Chronic kidney disease (CKD) is a high-cost chronic disease with costly complications, like hemodialysis, peritoneal dialysis, and cardiovascular diseases (CVDs). This study evaluated dapagliflozin cost-utility in patients with CKD in Costa Rica.

查看译文

关键词

dapagliflozin,chronic kidney disease,cost-utility

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要